Find News

Filter articles

Showing 11 to 20 of 3280 results

Arthrex prevails in patent dispute over wrist fracture device

US30-03-2021Legal developmentsMuireann Bolger

In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies.

Lundbeck loses €150m pay-for-delay appeal

EU30-03-2021Alex Baldwin

Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.

WHO urges vigilance against fake COVID-19 vaccines

29-03-2021Rory O'Neill

The World Health Organization has warned the public of the danger of counterfeit COVID-19 vaccines and urged people not to procure jabs outside of government channels.

Fed Circ. affirms Stanford genetics patent rejection

US26-03-2021Alex Baldwin

The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.

Supreme Court denies MS treatment patent petition

US25-03-2021Alex Baldwin

The US Supreme Court has denied a petition from Argentum Pharmaceuticals to review a Federal Circuit ruling covering a multiple sclerosis treatment patent.

Abbott unit prevails in dispute over catheter patent

US25-03-2021Muireann Bolger

In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.

Snyders revives patent claims against St Jude Medical

US25-03-2021Alex Baldwin

Snyders Heart Valve has been successful in reviving patent claims in an on-going dispute against St Jude Medical.

Wilson Sonsini adds Boston deals expert from Ropes & Gray

US23-03-2021Alex Baldwin

Wilson Sonsini & Rosati has hired Mark Bellomy as a partner for the firm’s technology transaction practice in Boston.

Pyxis secures ADC licence from Pfizer

US22-03-2021Rory O'Neill

Massachusetts-based biotechnology start-up Pyxis Oncology has secured a licensing deal with Pfizer for two of the pharmaceutical giant’s antibody-drug conjugates.

Reviewing the inter partes review

US22-03-2021Alex Baldwin

The establishment of the US Patent Trial and Appeal Board in 2012 changed the game for patent owners. And while life science patents have not always been under the spotlight, recent trends suggest more such patents are being reviewed than ever before.

Showing 11 to 20 of 3280 results